Fierce Biotech February 6, 2025
We hoped industry layoffs would relent in 2024. That’s not what happened.
Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data.
So, here we are, launching our fourth edition of Fierce Biotech’s layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team and let us know.
February—2 companies
Feb. 4 – Turnstone Biologics: The San Diego is seeking out “strategic alternatives” for its business and as it cuts work on a key pipeline program, it’s also wielding the ax on its staffers. By exactly how much, the biotech is not sharing, saying simply that it is “reducing its...